Robert C. Bast Jr.

Robert C. Bast Jr.
Robert C. Bast Jr.
Born	December 8, 1943
Alma mater	Wesleyan University; Harvard Medical School;
	Scientific career
Institutions	University of Texas MD Anderson Cancer Center
Website	faculty.mdanderson.org/profiles/robert_bast.html;

Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is currently Vice President for Translational Research at the University of Texas M.D. Anderson Cancer Center.^[1] Bast is best known for the discovery of CA125, a serum biomarker for ovarian cancer that has contributed to the care of ovarian cancer patients worldwide.^[2] His research spans early detection, enhancing chemotherapy and understanding regulation of dormancy and the role of autophagy in breast and ovarian cancer.

References

^ "Robert C. Bast". MD Anderson Cancer Center. Retrieved 2019-05-20.
^ "Robert C. Bast, Jr., M.D." NFCR. Retrieved 2019-05-20.

[1] "Robert C. Bast". MD Anderson Cancer Center. Retrieved 2019-05-20.

[2] "Robert C. Bast, Jr., M.D." NFCR. Retrieved 2019-05-20.

[1]

[2]

Authority control databases
International	ISNI VIAF WorldCat
National	Germany United States Czech Republic Netherlands Norway
Academics	ORCID ResearcherID Google Scholar Publons
Other	IdRef